Clinical Trial Update: Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating mesenchymal stromal cell therapy for acute respiratory distress syndrome, including COVID-19. The study is sponsored by U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Mesenchymal Stromal Cell Therapy

Snippet

Sponsor: Uppsala University | Conditions: ARDS, Human, COVID | Phase 1 | Status: ACTIVE_NOT_RECRUITING